Literature DB >> 3545644

Halothane hepatitis: a model of immune mediated drug hepatotoxicity.

J Neuberger, J G Kenna.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3545644     DOI: 10.1042/cs0720263

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


× No keyword cloud information.
  15 in total

1.  Retrospective study of post-anesthetic mild liver disorder associated with inhalation anesthetics, halothane and enflurane.

Authors:  Y Sakaguchi; S Inaba; Y Umeki; S Takahashi; J Yoshitake; Y Hayashi; K Akazawa; Y Nose
Journal:  J Anesth       Date:  1992-04       Impact factor: 2.078

Review 2.  Principles of pharmacotherapy: III. Drug allergy.

Authors:  T J Pallasch
Journal:  Anesth Prog       Date:  1988 Sep-Oct

3.  Human anti-endoplasmic reticulum antibodies in sera of patients with halothane-induced hepatitis are directed against a trifluoroacetylated carboxylesterase.

Authors:  H Satoh; B M Martin; A H Schulick; D D Christ; J G Kenna; L R Pohl
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

4.  The immunological basis of adverse drug reactions. A report on a symposium held in Liverpool on 6th April 1988.

Authors:  B K Park; J W Coleman
Journal:  Br J Clin Pharmacol       Date:  1988-11       Impact factor: 4.335

Review 5.  Immunological aspects of chronic active hepatitis.

Authors:  S Vento; A L Eddleston
Journal:  Clin Exp Immunol       Date:  1987-05       Impact factor: 4.330

6.  Halothane hepatitis in children.

Authors:  J G Kenna
Journal:  Br Med J (Clin Res Ed)       Date:  1987-09-26

Review 7.  Drug-induced "allergic hepatitis".

Authors:  P Podevin; M Biour
Journal:  Clin Rev Allergy Immunol       Date:  1995       Impact factor: 8.667

8.  Metabolism of ciamexon by human liver microsomes: an investigation into the formation of stable, chemically reactive and cytotoxic metabolites.

Authors:  M D Tingle; B K Park
Journal:  Br J Clin Pharmacol       Date:  1990-05       Impact factor: 4.335

9.  Absence of anti-trifluoroacetate antibody after halothane anaesthesia in patients exhibiting no or mild liver damage.

Authors:  Y Sakaguchi; S Inaba; K Irita; H Sakai; H Nawata; S Takahashi
Journal:  Can J Anaesth       Date:  1994-05       Impact factor: 5.063

Review 10.  The role of active metabolites in drug toxicity.

Authors:  M Pirmohamed; N R Kitteringham; B K Park
Journal:  Drug Saf       Date:  1994-08       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.